Company performance
Add to research
Current Price
as of Jun 18, 2025$1.41
P/E Ratio
N/A
Market Cap
$3.67M
Description
Add to research
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerONVO
- Price$1.4101-6.62%
Trading Information
- Market cap$3.67M
- Float98.64%
- Average Daily Volume (1m)64,053
- Average Daily Volume (3m)261,908
- EPS-$1.70
Company
- Revenue$0.14M
- Rev growth (1yr)32.11%
- Net income-$2.49M
- Gross margin-88.19%
- EBITDA margin-8,576.39%
- EBITDA-$12.35M
- EV-$6.96M
- EV/Revenue-48.36
- P/EN/A
- P/S14.33
- P/B0.26
- Debt/Equity10.20
Documents
Add to research
SEC Filings